Dendrimer Platform Technology

Starpharma aims to create value through the commercialisation of its proprietary products based on dendrimer nanotechnology.


Starpharma is commercialising products based on its proprietary dendrimer technology. The company hold more than 100 granted dendrimer patents covering a range of classes of this type of molecule.


Starpharma develops and commercialises dendrimer nanotechnology across diverse applications, including: